Hepion Pharmaceuticals
HEPA
#10712
Rank
A$0.62 M
Marketcap
A$0.05358
Share price
0.26%
Change (1 day)
-87.82%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2025 (TTM): -A$7.39 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$21.82 Million, an increase over its 2023 earnings that were of -A$69.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$7.39 Million-66.12%
2024 -A$21.82 Million-68.5%
2023 -A$69.26 Million9.74%
2022 -A$63.11 Million37.49%
2021 -A$45.9 Million61.27%
2020 -A$28.47 Million174.55%
2019 -A$10.37 Million-31.28%
2018 -A$15.09 Million
2016 -A$29.95 Million6.03%
2015 -A$28.24 Million265%
2014 -A$7.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.21 Billion 3,034.96%๐Ÿ‡บ๐Ÿ‡ธ USA